vs

Side-by-side financial comparison of FUEL TECH, INC. (FTEK) and Prelude Therapeutics Inc (PRLD). Click either name above to swap in a different company.

FUEL TECH, INC. is the larger business by last-quarter revenue ($7.2M vs $6.5M, roughly 1.1× Prelude Therapeutics Inc). On growth, Prelude Therapeutics Inc posted the faster year-over-year revenue change (116.7% vs 37.2%).

FTEK vs PRLD — Head-to-Head

Bigger by revenue
FTEK
FTEK
1.1× larger
FTEK
$7.2M
$6.5M
PRLD
Growing faster (revenue YoY)
PRLD
PRLD
+79.5% gap
PRLD
116.7%
37.2%
FTEK

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
FTEK
FTEK
PRLD
PRLD
Revenue
$7.2M
$6.5M
Net Profit
$-19.7M
Gross Margin
44.6%
Operating Margin
-19.7%
-314.1%
Net Margin
-303.5%
Revenue YoY
37.2%
116.7%
Net Profit YoY
38.9%
EPS (diluted)
$-0.05
$-0.26

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FTEK
FTEK
PRLD
PRLD
Q4 25
$7.2M
Q3 25
$7.5M
$6.5M
Q2 25
$5.6M
Q1 25
$6.4M
Q4 24
$5.3M
Q3 24
$7.9M
$3.0M
Q2 24
$7.0M
Q1 24
$5.0M
Net Profit
FTEK
FTEK
PRLD
PRLD
Q4 25
Q3 25
$303.0K
$-19.7M
Q2 25
$-689.0K
Q1 25
$-739.0K
Q4 24
Q3 24
$80.0K
$-32.3M
Q2 24
$-421.0K
Q1 24
$281.0K
Gross Margin
FTEK
FTEK
PRLD
PRLD
Q4 25
44.6%
Q3 25
48.9%
Q2 25
45.5%
Q1 25
46.4%
Q4 24
42.3%
Q3 24
43.4%
Q2 24
41.9%
Q1 24
40.9%
Operating Margin
FTEK
FTEK
PRLD
PRLD
Q4 25
-19.7%
Q3 25
0.1%
-314.1%
Q2 25
-23.5%
Q1 25
-14.9%
Q4 24
-40.1%
Q3 24
-2.3%
-1145.9%
Q2 24
-10.2%
Q1 24
-34.1%
Net Margin
FTEK
FTEK
PRLD
PRLD
Q4 25
Q3 25
4.0%
-303.5%
Q2 25
-12.4%
Q1 25
-11.6%
Q4 24
Q3 24
1.0%
-1075.7%
Q2 24
-6.0%
Q1 24
5.7%
EPS (diluted)
FTEK
FTEK
PRLD
PRLD
Q4 25
$-0.05
Q3 25
$0.01
$-0.26
Q2 25
$-0.02
Q1 25
$-0.02
Q4 24
$-0.06
Q3 24
$0.00
$-0.43
Q2 24
$-0.01
Q1 24
$0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FTEK
FTEK
PRLD
PRLD
Cash + ST InvestmentsLiquidity on hand
$24.9M
$55.0M
Total DebtLower is stronger
Stockholders' EquityBook value
$39.9M
$58.5M
Total Assets
$47.2M
$94.8M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FTEK
FTEK
PRLD
PRLD
Q4 25
$24.9M
Q3 25
$25.9M
$55.0M
Q2 25
$23.0M
Q1 25
$21.8M
Q4 24
$18.7M
Q3 24
$20.4M
$153.6M
Q2 24
$20.1M
Q1 24
$23.3M
Stockholders' Equity
FTEK
FTEK
PRLD
PRLD
Q4 25
$39.9M
Q3 25
$41.0M
$58.5M
Q2 25
$40.7M
Q1 25
$41.4M
Q4 24
$42.0M
Q3 24
$43.9M
$156.4M
Q2 24
$43.6M
Q1 24
$44.0M
Total Assets
FTEK
FTEK
PRLD
PRLD
Q4 25
$47.2M
Q3 25
$47.9M
$94.8M
Q2 25
$47.0M
Q1 25
$46.7M
Q4 24
$48.8M
Q3 24
$50.1M
$197.2M
Q2 24
$49.0M
Q1 24
$49.4M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FTEK
FTEK
PRLD
PRLD
Operating Cash FlowLast quarter
$-1.6M
$-19.1M
Free Cash FlowOCF − Capex
$-2.0M
FCF MarginFCF / Revenue
-27.7%
Capex IntensityCapex / Revenue
6.1%
0.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$2.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FTEK
FTEK
PRLD
PRLD
Q4 25
$-1.6M
Q3 25
$3.1M
$-19.1M
Q2 25
$-21.0K
Q1 25
$1.5M
Q4 24
$-1.6M
Q3 24
$879.0K
$-27.3M
Q2 24
$-1.6M
Q1 24
$-1.1M
Free Cash Flow
FTEK
FTEK
PRLD
PRLD
Q4 25
$-2.0M
Q3 25
$3.0M
Q2 25
$-57.0K
Q1 25
$1.4M
Q4 24
$-1.7M
Q3 24
$767.0K
$-27.4M
Q2 24
$-1.7M
Q1 24
$-1.2M
FCF Margin
FTEK
FTEK
PRLD
PRLD
Q4 25
-27.7%
Q3 25
39.6%
Q2 25
-1.0%
Q1 25
22.6%
Q4 24
-32.4%
Q3 24
9.8%
-912.0%
Q2 24
-23.8%
Q1 24
-24.0%
Capex Intensity
FTEK
FTEK
PRLD
PRLD
Q4 25
6.1%
Q3 25
1.7%
0.0%
Q2 25
0.6%
Q1 25
1.0%
Q4 24
1.2%
Q3 24
1.4%
2.1%
Q2 24
1.3%
Q1 24
2.3%
Cash Conversion
FTEK
FTEK
PRLD
PRLD
Q4 25
Q3 25
10.22×
Q2 25
Q1 25
Q4 24
Q3 24
10.99×
Q2 24
Q1 24
-3.83×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

FTEK
FTEK

Transferred At Point In Time$5.3M73%
Other$2.0M27%

PRLD
PRLD

Segment breakdown not available.

Related Comparisons